1.33
+0.027(+2.08%)
Currency In USD
| Previous Close | 1.3 |
| Open | 1.28 |
| Day High | 1.34 |
| Day Low | 1.28 |
| 52-Week High | 4.84 |
| 52-Week Low | 1.09 |
| Volume | 72,756 |
| Average Volume | 145,712 |
| Market Cap | 13.38M |
| PE | -1.77 |
| EPS | -0.75 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 1.87 |
| Change | 0.03 |
If you invested $1000 in Bullfrog AI Holdings, Inc. Common Stock (BFRG) since IPO date, it would be worth $204.15 as of September 13, 2025 at a share price of $1.327. Whereas If you bought $1000 worth of Bullfrog AI Holdings, Inc. Common Stock (BFRG) shares 1 year ago, it would be worth $562.29 as of September 13, 2025 at a share price of $1.327.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
GlobeNewswire Inc.
Sep 08, 2025 12:00 PM GMT
Joint oncology conference submission planned and follow-on contract discussion underway Validates BullFrog AI’s enterprise-grade platform strategy, combining automation and human-in-the-loop oversight for scalable, trustworthy analytics GAITHERSBURG
BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference
GlobeNewswire Inc.
Jul 28, 2025 8:30 PM GMT
GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence ("AI") and machine learning to enabl
Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
GlobeNewswire Inc.
Jul 22, 2025 12:00 PM GMT
From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ delivers what others can’t: biologically grounded